Tortora, Giampaolo et al
"Combined Targeted Inhibition of bcl-2, bcl-XL, Epidermal Growth Factor Receptor, and Protein Kinase A Type I Causes Potent Antitumor, Apoptotic, and Antiangiogenic Activity." Clinical Cancer Research
9.2
(2003):
866-871.
Web. 15 April. 2021.
